Stanford University
Showing 161-180 of 500 Results
-
John Higgins
Professor of Pathology
Current Research and Scholarly InterestsI work as a diagnostic surgical pathologist doing translational research in renal neoplasia and medical renal disease and neoplastic and medical liver disease. Subspecialty areas of clinical interest include diagnostic immunohistochemistry, renal, hepatic and transplant pathology.
-
Rory Hills
Postdoctoral Scholar, Pathology
BioI work at the intersection of protein engineering, immunology, and translational medicine. My research focuses on building generalizable molecular tools to better measure and manipulate complex human disease. At Stanford, I am developing modular antibody platforms that enable high-resolution, spatial analysis of cancer and immune systems in intact tissue. I previously trained at Oxford and Cambridge, where I worked on next-generation vaccine platforms with collaborators across academia and industry.
-
Jody Elizabeth Hooper
Professor of Pathology
Current Research and Scholarly InterestsI am the Director of the Research Autopsy Collaboration at Stanford (RACS) to collect organs and tissues from decedent donors for cancer and disease research. https://med.stanford.edu/racs
I have a number of research interests associated with my autopsy work, including how the time interval between death and collection (the PMI) affects the condition and research viability of the collected tissue, how valuable blood and tissue cultures behave after death, and how autopsy results affect clinical practice in an established information loop. I have projects exploring physician and family attitudes towards autopsy and the utilization of rapid autopsy tissue in characterizing cancer evolution from genetic and immunologic standpoints. -
Brooke Howitt
Irene Adler Professor
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Patrick David Hsu
Assistant Professor of Pathology
BioPatrick Hsu is Co-Founder of the Arc Institute and Assistant Professor of Pathology at Stanford University. The Hsu lab works at the intersection of biology and machine learning to develop technologies for biological and therapeutic design. Recent contributions include the Evo series of genome foundation models and the first universally programmable DNA recombinases. Patrick received A.M. and Ph.D. degrees from Harvard University and the Broad Institute of MIT and Harvard, where he was an early pioneer of CRISPR-Cas9 technologies for genome editing. His research has been recognized by awards from the New York Times, The Atlantic, Forbes, MIT Technology Review, Vox, Rainwater Foundation, and Amgen. He serves on the scientific advisory board of Amgen and the board of Stylus Medicine, and cofounded Fast Grants for rapid science funding.
-
Rongting Huang
Postdoctoral Scholar, Pathology
BioDr. Huang is a computational biologist with academic interests in cancer genomics and spatial biology, particularly in the field of gynecologic cancers. During her Ph.D. under the mentorship of Dr. Yuanhua Huang, she developed statistical methods to detect allele-specific somatic copy number variations from single-cell and spatial transcriptomic data, aiming to understand genetic diversity in biological systems. Currently, her research focuses on advancing gynecologic cancer studies and women’s health through spatial technology platforms, computational modeling, and innovative data visualizations to uncover meaningful insights.
Outside of research, she enjoys hiking, rock climbing, and calligraphy, which help her stay creative and balanced. -
Peter K. Jackson
Professor of Microbiology and Immunology (Baxter Labs) and of Pathology
Current Research and Scholarly InterestsDr. Jackson’s lab studies how primary cilia organize hormone, metabolite, and growth factor signaling in metabolic tissues and how their disruption causes obesity and diabetes. A second focus is defining the KRAS driven secreted factor networks that rewire the tumor microenvironment in lung and pancreatic cancers to promote immune evasion and therapeutic resistance. This work is revealing new secreted drug targets and combination strategies for precision oncology and metabolic disease.
-
Siddhartha Jaiswal
Associate Professor of Pathology
Current Research and Scholarly InterestsWe identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.
-
Olena Janczewski
Associate Director of Education, Pathology Ops Business Office
Current Role at StanfordAssociate Director of Education, Pathology
-
Kristin Jensen
Professor of Pathology
Current Research and Scholarly InterestsI am a clinical translational investigator with a primary interest in breast cancer biology, and the use of investigational and clinical ancillary techniques such as gene and tissue microarray analysis and immunohistochemistry in the diagnosis and prognosis of this disease. As a practicing cytopathologist, I also have an interest in improving the fine needle aspiration biopsy diagnosis of breast lesions, again using immunohistochemistry and gene expression analysis as adjuncts to cytomorphology.
-
Rathinaraja Jeyaraj
Postdoctoral Scholar, Pathology
BioI work at the intersection of AI, multimodal learning, and large-scale image analytics, with a strong focus on computational pathology and foundation models for healthcare. My current research interests include LLMs, VLMs, multimodal reasoning, whole-slide image analysis, retrieval-augmented generation (RAG), and trustworthy AI for medical decision support.
I develop scalable deep learning systems spanning WSI preprocessing, multiple instance learning, segmentation, survival prediction, and multimodal image-text modeling. My work also involves attention interpretability, contrastive learning, pathology foundation model adaptation, and large-scale AI pipelines. Beyond healthcare AI, I have experience in time-series forecasting, distributed computing, cloud infrastructure, and real-time computer vision systems for industrial and smart-city applications.
I am particularly interested in building reliable, interpretable, and clinically meaningful AI systems that bridge computer vision, multimodal learning, and large-scale reasoning. -
Jeyun Jo
Postdoctoral Scholar, Pathology
BioDr. Jeyun Jo received his Pharm.D. from Pusan National University in 2016 and his Ph.D. in pharmacy at the same institution in 2021. His thesis studies focused on the first total synthesis of anmindenol A and optimization of 2-anilinopyrimidine-based selective inhibitors against triple-negative breast cancer cells. He then worked for one year as a senior research scientist at Chong Kun Dang, a leading pharmaceutical company in Korea, where he developed large-sacale synthetic processes for engineered peptides. In May 2022, he joined the Bogyo lab at Stanford University as a postdoctoral fellow. His current research focuses on developing highly selective inhibitors and activity-based probes targeting specific serine hydrolases in pathogenic bacteria and cancer.
